UNSPSC 51143020: Aceglutamide aluminium

This classification denotes an anti-ulcer agent with the molecular structure 5C7H11N2O4.3AL.4HO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, R7QTG0PMPX chemically known as aluminium, pentakis(n(sup 2)-acetyl-l-glutaminato)tetrahydroxytri-, but more commonly known as aceglutamide aluminium, which bears US NIH Compound Identifier 25560. European Medicines Agency schedules Aceglutamide aluminium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00244MIG.

Most nations, for tariff and trade purposes, schedule aceglutamide aluminium under HS 29241900 and SITC 51471. SMILES: CC(=O)N[C@@H](CCC(=O)N)C(=O)[O-].CC(=O)N[C@@H](CCC(=O)N)C(=O)[O-].CC(=O)N[C@@H](CCC(=O)N)C(=O)[O-].CC(=O)N[C@@H](CCC(=O)N)C(=O)[O-].CC(=O)N[C@@H](CCC(=O)N)C(=O)[O-].[OH-].[OH-].[OH-].[OH-].[AL+3].[AL+3].[AL+3].

UNSPSC 51143020 Aceglutamide aluminium is a Commodity code for a specific pharmaceutical compound used in state and local procurement, though the source provides no recent contract opportunities under this code. The code appears to designate a pharmaceutical ingredient or formulation rather than a broad service or product family, and without active solicitation records, no concrete framing of current buying patterns is available from state and local jurisdictions.

Because no recent state and local opportunities are documented in the source, characterization of issuing-body mix, geographic concentration, or representative recent solicitations is not supported. State and local purchasing offices rarely solicit individual pharmaceutical compounds through standard procurement channels outside of bulk drug purchasing programs or specialized health-care contracting vehicles; this code may see activity through state health departments, correctional systems, or regional healthcare authorities if at all, but current market signals are absent from available records.